Bionoid Pharma Inc.
BINP
$0.08
$0.000.00%
OTC PK
| 03/31/2011 | |||||
|---|---|---|---|---|---|
| Net Income | -202.40% | ||||
| Total Depreciation and Amortization | -1.20% | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | 344.41% | ||||
| Change in Net Operating Assets | -28.79% | ||||
| Cash from Operations | -3.07% | ||||
| Capital Expenditure | 94.87% | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -- | ||||
| Cash from Investing | 94.87% | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | -101.31% | ||||
| Foreign Exchange rate Adjustments | -83.09% | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -176.47% | ||||